Technical Analysis for OGEN - Oragenics, Inc.

Grade Last Price % Change Price Change
grade F 0.62 1.64% 0.01
OGEN closed up 1.64 percent on Friday, March 22, 2019, on 1.4 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical OGEN trend table...

Date Alert Name Type % Chg
Mar 22 Calm After Storm Range Contraction 0.00%
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 22 Lower Bollinger Band Walk Weakness 0.00%
Mar 22 Stochastic Reached Oversold Weakness 0.00%
Mar 22 Inside Day Range Contraction 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Oversold Stochastic Weakness 0.00%
Mar 21 MACD Bearish Signal Line Cross Bearish 1.64%

Older signals for OGEN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.
Medicine Health Healthcare Health Care Antibiotics Antibiotic Healthcare Associated Infections Bacteriology Digestive System Oral Hygiene
Is OGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.74
52 Week Low 0.38
Average Volume 1,529,844
200-Day Moving Average 0.9311
50-Day Moving Average 0.903
20-Day Moving Average 0.8527
10-Day Moving Average 0.8284
Average True Range 0.0637
ADX 22.39
+DI 17.3357
-DI 37.9121
Chandelier Exit (Long, 3 ATRs ) 0.7989
Chandelier Exit (Short, 3 ATRs ) 0.7922
Upper Bollinger Band 1.0212
Lower Bollinger Band 0.6842
Percent B (%b) -0.19
BandWidth 39.52152
MACD Line -0.0426
MACD Signal Line -0.0196
MACD Histogram -0.0231
Fundamentals Value
Market Cap 30.54 Million
Num Shares 49.3 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -3.90
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.65
Resistance 3 (R3) 0.65 0.64 0.65
Resistance 2 (R2) 0.64 0.63 0.64 0.64
Resistance 1 (R1) 0.63 0.63 0.63 0.63 0.64
Pivot Point 0.62 0.62 0.62 0.62 0.62
Support 1 (S1) 0.61 0.61 0.61 0.61 0.60
Support 2 (S2) 0.60 0.61 0.60 0.60
Support 3 (S3) 0.59 0.60 0.60
Support 4 (S4) 0.59